Stephen Antonysamy
Impact in
-
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Protein Degradation and Inhibitors
-
- Inflammatory mediators and NSAID effects
Papers in
-
- Cancer-related gene regulation 4
- Epigenetics and DNA Methylation 4
- Biochemical and Molecular Research 2
- Glycosylation and Glycoproteins Research 2
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Marijane Russell (4 shared papers)Zahid Bonday (2 shared papers)Robert M. Campbell (2 shared papers)Zhanna Druzina (3 shared papers)Kenneth Weichert (2 shared papers)Aiping Zhang (2 shared papers)T. Gheyi (2 shared papers)Stephen R. Wasserman (2 shared papers)
- Journals
- PLoS ONE (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Cancer Research (2 papers)mAbs (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Stephen Antonysamy
14 papers receiving 707 citations
Peers
Comparison fields: 5 of 60
- Molecular Biology 571
- Pharmacology 59
- Computational Theory and Mathematics 50
- Oncology 76
- Organic Chemistry 76
Countries citing papers authored by Stephen Antonysamy
This map shows the geographic impact of Stephen Antonysamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Antonysamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Antonysamy more than expected).
Fields of papers citing papers by Stephen Antonysamy
This network shows the impact of papers produced by Stephen Antonysamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Antonysamy. The network helps show where Stephen Antonysamy may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Antonysamy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 256 | |
| 2 | 2018 | 119 | |
| 3 | 2013 | 68 | |
| 4 | 2008 | 64 | |
| 5 | 2015 | 54 | |
| 6 | 2008 | 52 | |
| 7 | 2017 | 33 | |
| 8 | 2018 | 21 | |
| 9 | 2020 | 17 | |
| 10 | 2020 | 14 | |
| 11 | 2024 | 9 | |
| 12 | 2019 | 9 | |
| 13 | 2019 | 6 | |
| 14 | 2019 | 1 |
About Stephen Antonysamy
Stephen Antonysamy is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology, Oncology and Pharmacology, having authored 14 papers that have together received 723 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Cancer-related gene regulation (4 papers), Epigenetics and DNA Methylation (4 papers), Galectins and Cancer Biology (3 papers), Biochemical and Molecular Research (2 papers), Glycosylation and Glycoproteins Research (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Molecular Biology (571 citations), Pharmacology (59 citations), Computational Theory and Mathematics (50 citations), Oncology (76 citations) and Organic Chemistry (76 citations). Stephen Antonysamy has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Marijane Russell, Zahid Bonday, Robert M. Campbell, Zhanna Druzina, Kenneth Weichert, Aiping Zhang, T. Gheyi, Stephen R. Wasserman, J.M. Sauder and Charles T. Rauch. Their work appears in journals such as PLoS ONE, Bioorganic & Medicinal Chemistry Letters, Cancer Research, mAbs and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.